世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Hepatic Porphyria Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5564 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、急性肝性ポルフィリン症用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（350 Mg、313 Mg）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・急性肝性ポルフィリン症用医薬品の市場動向 ・企業の競争状況、市場シェア ・急性肝性ポルフィリン症用医薬品の種類別市場規模と予測2016-2027（350 Mg、313 Mg） ・急性肝性ポルフィリン症用医薬品の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局、その他） ・急性肝性ポルフィリン症用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・急性肝性ポルフィリン症用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性肝性ポルフィリン症用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性肝性ポルフィリン症用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性肝性ポルフィリン症用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alnylam Pharmaceuticals、Recordati Rare Diseases） ・結論

Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria.

Market Analysis and Insights: Global Acute Hepatic Porphyria Drug Market
The global Acute Hepatic Porphyria Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Hepatic Porphyria Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Hepatic Porphyria Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Hepatic Porphyria Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Hepatic Porphyria Drug market.

Global Acute Hepatic Porphyria Drug Scope and Market Size
Acute Hepatic Porphyria Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Hepatic Porphyria Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
350 Mg
313 Mg

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alnylam Pharmaceuticals
Recordati Rare Diseases

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 350 Mg
1.2.3 313 Mg
1.3 Market by Application
1.3.1 Global Acute Hepatic Porphyria Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Hepatic Porphyria Drug Market Perspective (2016-2027)
2.2 Acute Hepatic Porphyria Drug Growth Trends by Regions
2.2.1 Acute Hepatic Porphyria Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Hepatic Porphyria Drug Historic Market Share by Regions (2016-2021)
2.2.3 Acute Hepatic Porphyria Drug Forecasted Market Size by Regions (2022-2027)
2.3 Acute Hepatic Porphyria Drug Industry Dynamic
2.3.1 Acute Hepatic Porphyria Drug Market Trends
2.3.2 Acute Hepatic Porphyria Drug Market Drivers
2.3.3 Acute Hepatic Porphyria Drug Market Challenges
2.3.4 Acute Hepatic Porphyria Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Hepatic Porphyria Drug Players by Revenue
3.1.1 Global Top Acute Hepatic Porphyria Drug Players by Revenue (2016-2021)
3.1.2 Global Acute Hepatic Porphyria Drug Revenue Market Share by Players (2016-2021)
3.2 Global Acute Hepatic Porphyria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Hepatic Porphyria Drug Revenue
3.4 Global Acute Hepatic Porphyria Drug Market Concentration Ratio
3.4.1 Global Acute Hepatic Porphyria Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Hepatic Porphyria Drug Revenue in 2020
3.5 Acute Hepatic Porphyria Drug Key Players Head office and Area Served
3.6 Key Players Acute Hepatic Porphyria Drug Product Solution and Service
3.7 Date of Enter into Acute Hepatic Porphyria Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Hepatic Porphyria Drug Breakdown Data by Type
4.1 Global Acute Hepatic Porphyria Drug Historic Market Size by Type (2016-2021)
4.2 Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2022-2027)

5 Acute Hepatic Porphyria Drug Breakdown Data by Application
5.1 Global Acute Hepatic Porphyria Drug Historic Market Size by Application (2016-2021)
5.2 Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Hepatic Porphyria Drug Market Size (2016-2027)
6.2 North America Acute Hepatic Porphyria Drug Market Size by Type
6.2.1 North America Acute Hepatic Porphyria Drug Market Size by Type (2016-2021)
6.2.2 North America Acute Hepatic Porphyria Drug Market Size by Type (2022-2027)
6.2.3 North America Acute Hepatic Porphyria Drug Market Size by Type (2016-2027)
6.3 North America Acute Hepatic Porphyria Drug Market Size by Application
6.3.1 North America Acute Hepatic Porphyria Drug Market Size by Application (2016-2021)
6.3.2 North America Acute Hepatic Porphyria Drug Market Size by Application (2022-2027)
6.3.3 North America Acute Hepatic Porphyria Drug Market Size by Application (2016-2027)
6.4 North America Acute Hepatic Porphyria Drug Market Size by Country
6.4.1 North America Acute Hepatic Porphyria Drug Market Size by Country (2016-2021)
6.4.2 North America Acute Hepatic Porphyria Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acute Hepatic Porphyria Drug Market Size (2016-2027)
7.2 Europe Acute Hepatic Porphyria Drug Market Size by Type
7.2.1 Europe Acute Hepatic Porphyria Drug Market Size by Type (2016-2021)
7.2.2 Europe Acute Hepatic Porphyria Drug Market Size by Type (2022-2027)
7.2.3 Europe Acute Hepatic Porphyria Drug Market Size by Type (2016-2027)
7.3 Europe Acute Hepatic Porphyria Drug Market Size by Application
7.3.1 Europe Acute Hepatic Porphyria Drug Market Size by Application (2016-2021)
7.3.2 Europe Acute Hepatic Porphyria Drug Market Size by Application (2022-2027)
7.3.3 Europe Acute Hepatic Porphyria Drug Market Size by Application (2016-2027)
7.4 Europe Acute Hepatic Porphyria Drug Market Size by Country
7.4.1 Europe Acute Hepatic Porphyria Drug Market Size by Country (2016-2021)
7.4.2 Europe Acute Hepatic Porphyria Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Hepatic Porphyria Drug Market Size (2016-2027)
8.2 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Type
8.2.1 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Application
8.3.1 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region
8.4.1 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Hepatic Porphyria Drug Market Size (2016-2027)
9.2 Latin America Acute Hepatic Porphyria Drug Market Size by Type
9.2.1 Latin America Acute Hepatic Porphyria Drug Market Size by Type (2016-2021)
9.2.2 Latin America Acute Hepatic Porphyria Drug Market Size by Type (2022-2027)
9.2.3 Latin America Acute Hepatic Porphyria Drug Market Size by Type (2016-2027)
9.3 Latin America Acute Hepatic Porphyria Drug Market Size by Application
9.3.1 Latin America Acute Hepatic Porphyria Drug Market Size by Application (2016-2021)
9.3.2 Latin America Acute Hepatic Porphyria Drug Market Size by Application (2022-2027)
9.3.3 Latin America Acute Hepatic Porphyria Drug Market Size by Application (2016-2027)
9.4 Latin America Acute Hepatic Porphyria Drug Market Size by Country
9.4.1 Latin America Acute Hepatic Porphyria Drug Market Size by Country (2016-2021)
9.4.2 Latin America Acute Hepatic Porphyria Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Hepatic Porphyria Drug Market Size (2016-2027)
10.2 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type
10.2.1 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application
10.3.1 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country
10.4.1 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Acute Hepatic Porphyria Drug Business (2016-2021)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Recordati Rare Diseases
11.2.1 Recordati Rare Diseases Company Details
11.2.2 Recordati Rare Diseases Business Overview
11.2.3 Recordati Rare Diseases Acute Hepatic Porphyria Drug Introduction
11.2.4 Recordati Rare Diseases Revenue in Acute Hepatic Porphyria Drug Business (2016-2021)
11.2.5 Recordati Rare Diseases Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 350 Mg
Table 3. Key Players of 313 Mg
Table 4. Global Acute Hepatic Porphyria Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acute Hepatic Porphyria Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Hepatic Porphyria Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acute Hepatic Porphyria Drug Market Share by Regions (2016-2021)
Table 8. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acute Hepatic Porphyria Drug Market Share by Regions (2022-2027)
Table 10. Acute Hepatic Porphyria Drug Market Trends
Table 11. Acute Hepatic Porphyria Drug Market Drivers
Table 12. Acute Hepatic Porphyria Drug Market Challenges
Table 13. Acute Hepatic Porphyria Drug Market Restraints
Table 14. Global Acute Hepatic Porphyria Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acute Hepatic Porphyria Drug Market Share by Players (2016-2021)
Table 16. Global Top Acute Hepatic Porphyria Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Hepatic Porphyria Drug as of 2020)
Table 17. Ranking of Global Top Acute Hepatic Porphyria Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acute Hepatic Porphyria Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Hepatic Porphyria Drug Product Solution and Service
Table 21. Date of Enter into Acute Hepatic Porphyria Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Hepatic Porphyria Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acute Hepatic Porphyria Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acute Hepatic Porphyria Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acute Hepatic Porphyria Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acute Hepatic Porphyria Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acute Hepatic Porphyria Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acute Hepatic Porphyria Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acute Hepatic Porphyria Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acute Hepatic Porphyria Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acute Hepatic Porphyria Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acute Hepatic Porphyria Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acute Hepatic Porphyria Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acute Hepatic Porphyria Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acute Hepatic Porphyria Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acute Hepatic Porphyria Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acute Hepatic Porphyria Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acute Hepatic Porphyria Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acute Hepatic Porphyria Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acute Hepatic Porphyria Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acute Hepatic Porphyria Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acute Hepatic Porphyria Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acute Hepatic Porphyria Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Alnylam Pharmaceuticals Company Details
Table 62. Alnylam Pharmaceuticals Business Overview
Table 63. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product
Table 64. Alnylam Pharmaceuticals Revenue in Acute Hepatic Porphyria Drug Business (2016-2021) & (US$ Million)
Table 65. Alnylam Pharmaceuticals Recent Development
Table 66. Recordati Rare Diseases Company Details
Table 67. Recordati Rare Diseases Business Overview
Table 68. Recordati Rare Diseases Acute Hepatic Porphyria Drug Product
Table 69. Recordati Rare Diseases Revenue in Acute Hepatic Porphyria Drug Business (2016-2021) & (US$ Million)
Table 70. Recordati Rare Diseases Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Hepatic Porphyria Drug Market Share by Type: 2020 VS 2027
Figure 2. 350 Mg Features
Figure 3. 313 Mg Features
Figure 4. Global Acute Hepatic Porphyria Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Hepatic Porphyria Drug Report Years Considered
Figure 10. Global Acute Hepatic Porphyria Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Hepatic Porphyria Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Hepatic Porphyria Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Hepatic Porphyria Drug Market Share by Regions (2022-2027)
Figure 14. Global Acute Hepatic Porphyria Drug Market Share by Players in 2020
Figure 15. Global Top Acute Hepatic Porphyria Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Hepatic Porphyria Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Hepatic Porphyria Drug Revenue in 2020
Figure 17. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Hepatic Porphyria Drug Market Share by Type (2016-2027)
Figure 21. North America Acute Hepatic Porphyria Drug Market Share by Application (2016-2027)
Figure 22. North America Acute Hepatic Porphyria Drug Market Share by Country (2016-2027)
Figure 23. United States Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Hepatic Porphyria Drug Market Share by Type (2016-2027)
Figure 27. Europe Acute Hepatic Porphyria Drug Market Share by Application (2016-2027)
Figure 28. Europe Acute Hepatic Porphyria Drug Market Share by Country (2016-2027)
Figure 29. Germany Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Hepatic Porphyria Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Hepatic Porphyria Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Hepatic Porphyria Drug Market Share by Region (2016-2027)
Figure 39. China Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Hepatic Porphyria Drug Market Share by Type (2016-2027)
Figure 47. Latin America Acute Hepatic Porphyria Drug Market Share by Application (2016-2027)
Figure 48. Latin America Acute Hepatic Porphyria Drug Market Share by Country (2016-2027)
Figure 49. Mexico Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Hepatic Porphyria Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Hepatic Porphyria Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Hepatic Porphyria Drug Market Share by Country (2016-2027)
Figure 55. Turkey Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Hepatic Porphyria Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Alnylam Pharmaceuticals Revenue Growth Rate in Acute Hepatic Porphyria Drug Business (2016-2021)
Figure 59. Recordati Rare Diseases Revenue Growth Rate in Acute Hepatic Porphyria Drug Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

---